-+ 0.00%
-+ 0.00%
-+ 0.00%

MAIA BIOTECHNOLOGY REPORTS PIVOTAL PHASE 3 CLINICAL TRIAL PROGRESS IN ADVANCED NON-SMALL CELL LUNG CANCER

Reuters·09/22/2026 12:49:19